By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Citigroup yesterday revised its estimates for Life Technologies and Illumina, lowering fourth-quarter 2011 earnings per share estimates for Life Tech while raising EPS for Illumina.

Analyst Amit Bhalla lowered his EPS estimate for Life Tech for the fourth quarter to $1.03 from $1.06, while also reducing his revenue estimate for full-year 2011 to $3.72 billion from an earlier estimate of $3.74 billion. EPS for the full year was lowered to $3.70 from $3.73.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.